Case report: a transcatheter aortic valve replacement failure secondary to COVID-19 infection.

ABSTRACT:

Background

Valve thrombosis is a well-documented cause of bioprosthetic valve failure. Case reports have been published of prosthetic valve thrombosis secondary to COVID-19 infection. This is the first case report of COVID-19 associated valve thrombosis in a patient with transcatheter aortic valve replacement (TAVR).

Case summary

A 90-year-old female with atrial fibrillation on therapeutic apixaban and status-post TAVR presented with COVID-19 infection and was found to have severe bioprosthetic valvular regurgitation with features suggestive of valve thrombosis. She underwent valve-in-valve TAVR with resolution of valvular dysfunction.

Discussion

This case report contributes to a growing body of evidence describing the occurrence of thrombotic complications in patient

SUBMITTER: Tacon PR 

PROVIDER: S-EPMC9949707 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature